Profound Medical Q3 EPS USD -0.21

PROF•2026-11-05

Profound Medical reported third-quarter EPS of USD -0.21, operating expenses of USD 15.5 million, a net loss of USD 7.7 million and revenue of USD 9.8 million.

1. Third-quarter results

Profound Medical reported third-quarter EPS of USD -0.21. Operating expenses were USD 15.5 million, net income was USD -7.7 million and revenue was USD 9.8 million.

Profound Medical Q3 EPS USD -0.21

1. Third-quarter results

Related News

CarGurus Q3 adjusted EBITDA beats estimates on dealer growth

Trupanion Q3 revenue slightly beats estimates on subscription growth

Willdan completes $285 million acquisition of Mantis Innovation

Genpact Q3 revenue slightly beats estimates, driven by Advanced Technology Solutions

Citizens Q3 revenue rises 4% as premium growth offsets lower investment income